Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3018]
News [6108]
Articles [120]
Editorials [18]
Conferences [179]
elearning [32]
Uganda as a case study for cancer care initiatives in Africa
Dr Warren Phipps - Fred Hutchinson Cancer Research Center, Seattle, USA
Uganda as a case study for cancer care initiatives in Africa ( Dr Warren Phipps - Fred Hutchinson Cancer Research Center, Seattle, USA )
28 Feb 2020
Shorter hormone therapy for prostate cancer
Dr André-Guy Martin - Centre Hospitalier Universitaire de Québec, Québec City...
Shorter hormone therapy for prostate cancer ( Dr André-Guy Martin - Centre Hospitalier Universitaire de Québec, Québec City, Canada )
24 Feb 2020
Over-diagnosis of low-grade prostate cancer, good or bad?
Prof Hendrik Van Poppel - KU Leuven, Leuven, Belgium
Over-diagnosis of low-grade prostate cancer, good or bad? ( Prof Hendrik Van Poppel - KU Leuven, Leuven, Belgium )
24 Feb 2020
Treatment of early stage adenocarcinoma
Dr C S Pramesh - Tata Memorial Hospital, Mumbai, India
Treatment of early stage adenocarcinoma ( Dr C S Pramesh - Tata Memorial Hospital, Mumbai, India )
20 Feb 2020
Treatment of early stage cervical and ovarian cancer
Dr Rama Joshi - Foirtis Memorial Research Institute, Gurgaon, India
Treatment of early stage cervical and ovarian cancer ( Dr Rama Joshi - Foirtis Memorial Research Institute, Gurgaon, India )
20 Feb 2020
EV-103: Enfortumab vedotin plus pembrolizumab for locally advanced or...
Dr Jonathan Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA
EV-103: Enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma ( Dr Jonathan Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA )
19 Feb 2020
RADVAX: Nivolumab / ipilimumab with SBRT for metastatic renal cell carcinoma
Dr Hans Hammers - UT Southwestern Medical Center, Dallas, USA
RADVAX: Nivolumab / ipilimumab with SBRT for metastatic renal cell carcinoma ( Dr Hans Hammers - UT Southwestern Medical Center, Dallas, USA )
19 Feb 2020
CHAARTED: Luminal B subtype as a biomarker of docetaxel benefit for mHSPC
Dr Anis Hamid - Dana-Farber Cancer Institute, Boston, USA
CHAARTED: Luminal B subtype as a biomarker of docetaxel benefit for mHSPC ( Dr Anis Hamid - Dana-Farber Cancer Institute, Boston, USA )
19 Feb 2020
Cytoreductive nephrectomy for mRCC treated with immune checkpoint inhibitors or...
Dr Ziad Bakouny - Dana-Farber Cancer Institute, Boston, USA
Cytoreductive nephrectomy for mRCC treated with immune checkpoint inhibitors or targeted therapy ( Dr Ziad Bakouny - Dana-Farber Cancer Institute, Boston, USA )
18 Feb 2020
ASCO GU 2020: Bladder: Genomic profiling, real-world treatment challenges and...
Dr Petros Grivas, Dr Shilpa Gupta, Dr Alison Birtle and Dr Joseph Jacob
ASCO GU 2020: Bladder: Genomic profiling, real-world treatment challenges and novel agents ( Dr Petros Grivas, Dr Shilpa Gupta, Dr Alison Birtle and Dr Joseph Jacob )
14 Feb 2020
Latest advances in mHSPC from ASCO GU 2020
Dr Eleni Efstathiou and Prof Axel Merseburger
Latest advances in mHSPC from ASCO GU 2020 ( Dr Eleni Efstathiou and Prof Axel Merseburger )
14 Feb 2020
Cancer genetics in the clinic: Ready for 'prime time'?
Dr Ophira Ginsburg - NYU Langone Health, New York City, USA
Cancer genetics in the clinic: Ready for 'prime time'? ( Dr Ophira Ginsburg - NYU Langone Health, New York City, USA )
14 Feb 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation